Combined fibrinogen and neutrophil‐lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma

Patients with advanced esophageal squamous cell carcinoma (ESCC) is received chemoradiotherapy or chemotherapy for clinical management. However, it is difficult to predict tumor response and prognosis using blood markers before starting treatments. The purpose of this study was to investigate the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kijima, Takashi, Arigami, Takaaki, Uchikado, Yasuto, Uenosono, Yoshikazu, Kita, Yoshiaki, Owaki, Tetsuhiro, Mori, Shinichiro, Kurahara, Hiroshi, Kijima, Yuko, Okumura, Hiroshi, Maemura, Kosei, Ishigami, Sumiya, Natsugoe, Shoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329150/
https://www.ncbi.nlm.nih.gov/pubmed/27889946
http://dx.doi.org/10.1111/cas.13127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329150/
https://www.ncbi.nlm.nih.gov/pubmed/27889946
http://dx.doi.org/10.1111/cas.13127

Ejemplares similares